Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Almorexant (ACT 078573) is a potent and competitive dual orexin 1 receptor (OX1)/orexin 2 receptor (OX2) antagonist with Ki values of 1.3 and 0.17 nM for OX1 and OX2, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 44.00 | |
2 mg | In stock | $ 63.00 | |
5 mg | In stock | $ 97.00 | |
10 mg | In stock | $ 178.00 | |
25 mg | In stock | $ 333.00 | |
50 mg | In stock | $ 555.00 | |
100 mg | In stock | $ 798.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 109.00 |
Description | Almorexant (ACT 078573) is a potent and competitive dual orexin 1 receptor (OX1)/orexin 2 receptor (OX2) antagonist with Ki values of 1.3 and 0.17 nM for OX1 and OX2, respectively. |
Targets&IC50 | OX2:0.17 nM(ki), OX1:1.3 nM(ki) |
Synonyms | ACT 078573 |
Molecular Weight | 512.56 |
Formula | C29H31F3N2O3 |
CAS No. | 871224-64-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (87.79 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Almorexant 871224-64-5 GPCR/G Protein Neuroscience OX Receptor pancreatic cancer Orexin Receptor (OX Receptor) Pancreatic ductal adenocarcinoma Cataplexy HCRT Receptor Inhibitor ACT078573 Apoptosis GPCR orexin Hypocretin Receptor Ca2+ channels narcolepsy Caspase HPAF-II cells ACT-078573 AsPC-1 cells Calcium Channel Ca channels hypocretin ACT 078573 inhibit PDAC inhibitor